Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Kakkar

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|December 20, 2013
The roles of microRNAs in atherosclerosisXinjie Lu, Vijay Kakkar
Current Pharmaceutical Design|August 16, 2013
Inflammasome and atherogenesisXinjie Lu, Vijay Kakkar
Current Medicinal Chemistry|December 8, 2015
Essential Roles of Toll-Like Receptors in AtherosclerosisJuntang Lin, Vijay Kakkar, Xinjie Lu
Current Pharmaceutical Design|November 5, 2015
The role of interleukin 35 in atherosclerosisJuntang Lin, Vijay Kakkar, Xinjie Lu
Current Pharmaceutical Design|May 28, 2014
Impact of MCP-1 in atherosclerosisJuntang Lin, Vijay Kakkar, Xinjie Lu
Current Drug Targets|February 13, 2014
Impact of matrix metalloproteinases on atherosclerosisJuntang Lin, Vijay Kakkar, Xinjie Lu
Current Pharmaceutical Design|September 16, 2015
The role of interleukin 35 in atherosclerosisJuntang Lin, Vijay Kakkar, Xinjie Lu
Toxins|November 10, 2011
ADAM-15 disintegrin-like domain structure and functionDong Lu, Mike Scully, Vijay Kakkar, et al.
Current Cancer Drug Targets|December 17, 2008
ADAM proteins - therapeutic potential in cancerXinjie Lu, Dong Lu, Mike Scully, et al.
Perspectives in Medicinal Chemistry|September 30, 2009
The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapyXinjie Lu, Dong Lu, Mike Scully, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|December 20, 2013
The roles of microRNAs in atherosclerosisXinjie Lu, Vijay Kakkar
Current Pharmaceutical Design|August 16, 2013
Inflammasome and atherogenesisXinjie Lu, Vijay Kakkar
Current Medicinal Chemistry|December 8, 2015
Essential Roles of Toll-Like Receptors in AtherosclerosisJuntang Lin, Vijay Kakkar, Xinjie Lu
Current Pharmaceutical Design|November 5, 2015
The role of interleukin 35 in atherosclerosisJuntang Lin, Vijay Kakkar, Xinjie Lu
Current Pharmaceutical Design|May 28, 2014
Impact of MCP-1 in atherosclerosisJuntang Lin, Vijay Kakkar, Xinjie Lu
Current Drug Targets|February 13, 2014
Impact of matrix metalloproteinases on atherosclerosisJuntang Lin, Vijay Kakkar, Xinjie Lu
Current Pharmaceutical Design|September 16, 2015
The role of interleukin 35 in atherosclerosisJuntang Lin, Vijay Kakkar, Xinjie Lu
Toxins|November 10, 2011
ADAM-15 disintegrin-like domain structure and functionDong Lu, Mike Scully, Vijay Kakkar, et al.
Current Cancer Drug Targets|December 17, 2008
ADAM proteins - therapeutic potential in cancerXinjie Lu, Dong Lu, Mike Scully, et al.
Perspectives in Medicinal Chemistry|September 30, 2009
The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapyXinjie Lu, Dong Lu, Mike Scully, et al.
Pageof 2